title: Versican and the control of inflammation.
abstract: Versican is an extracellular matrix (ECM) proteoglycan that interacts with cells by binding to non-integrin and integrin receptors and to other ECM components that associate with the cell surface. Recent studies have shown also that versican interacts with myeloid and lymphoid cells promoting their adhesion and production of inflammatory cytokines. Versican is produced by stromal cells, as well as leukocytes, and is markedly increased in inflammation. Inflammatory agonists, such as double-stranded RNA mimetics (e.g., poly I:C), stimulate stromal cells, smooth muscle cells and fibroblasts, to produce fibrillar ECMs enriched in versican and hyaluronan (HA) that interact with leukocytes promoting their adhesion. Interference with the incorporation of versican into this ECM blocks monocyte adhesion and dampens the inflammatory response. Tumor cells also express elevated levels of versican which interact with myeloid cells to promote an inflammatory response, through stimulating cytokine release, and metastasis. In addition, myeloid cells, such as macrophages in tumors, synthesize versican which affects tumor cell phenotypes, inflammation, and subsequent metastasis. Versican, by binding to hyaluronan, influences T lymphocyte phenotypes and in part controls the ability of these cells to synthesize and secrete cytokines that influence the immune response. Collectively, these studies indicate that versican as an ECM molecule plays a central role in inflammation and as a result it is emerging as a potential target promising wide therapeutic benefits.
authors: Matrix Biology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA. Electronic address: twight@benaroyaresearch.org.
authors: Thomas N
authors: TN
authors: Wight
authors: Matrix Biology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA.
authors: Inkyung
authors: I
authors: Kang
authors: Department of Anatomy with Radiology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
authors: Mervyn J
authors: MJ
authors: Merrilees
mesh_terms: D000818:Animals; D002448:Cell Adhesion / Q000502:physiology*; D005109:Extracellular Matrix / Q000378:metabolism*; D005822:Genetic Vectors; D006801:Humans; D007249:Inflammation / Q000378:metabolism / Q000517:prevention & control*; D008213:Lymphocyte Activation / Q000276:immunology*; D008214:Lymphocytes / Q000378:metabolism; D051379:Mice; D008954:Models, Biological; D015394:Molecular Structure; D022423:Myeloid Cells / Q000378:metabolism; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism; D012190:Retroviridae; D013601:T-Lymphocytes / Q000502:physiology; D014161:Transduction, Genetic; D053675:Versicans / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*
chemical_list: D020033:Protein Isoforms; D053675:Versicans
keywords: Hyaluronan; Immunity; Inflammation; Macrophages; T lymphocytes; Versican